Literature DB >> 2849488

The effects of 1,25-dihydroxyvitamin D3 on growth, alkaline phosphatase and adenylate cyclase of rat osteoblast-like cells.

H A Pols1, H P Schilte, N M Herrmann-Erlee, T J Visser, J C Birkenhäger.   

Abstract

1,25(OH)2D3 induced a dose-dependent increase of alkaline phosphatase activity in primary cultures of fetal rat osteoblast-like cells. A slight decrease in final DNA content was found in densely seeded cultures and at 10(-8) M 1,25(OH)2D3 only. Furthermore, 1,25(OH)2D3 treatment resulted in an attenuation of the cAMP response to PTH without an effect on the EC50 of PTH. On the other hand no change of the cAMP response to forskolin was observed. Forskolin partly restored the decline in the PTH-stimulated adenylate cyclase activity. The results indicate that physiological concentrations of 1,25(OH)2D3 have a stimulatory effect on the alkaline phosphatase of osteoblast-like cells and decrease the responsiveness of these cultures to PTH. We propose that the site of action of 1,25(OH)2D3 in the adenylate cyclase system is either at the level of the regulatory unit or on the interaction of the regulatory with the catalytic unit.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2849488

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  4 in total

1.  Expression of the parathyroid hormone receptor and correlation with other osteoblastic parameters in fetal rat osteoblasts.

Authors:  M P Bos; J M van der Meer; J H Feyen; M P Herrmann-Erlee
Journal:  Calcif Tissue Int       Date:  1996-02       Impact factor: 4.333

2.  Modulation by epidermal growth factor of the basal 1,25(OH)2D3 receptor level and the heterologous up-regulation of the 1,25(OH)2D3 receptor in clonal osteoblast-like cells.

Authors:  J P van Leeuwen; H A Pols; J P Schilte; T J Visser; J C Birkenhäger
Journal:  Calcif Tissue Int       Date:  1991-07       Impact factor: 4.333

3.  Rapid stimulation of Na+/H+ exchange by 1,25-dihydroxyvitamin D3; interaction with parathyroid-hormone-dependent inhibition.

Authors:  U Binswanger; C Helmle-Kolb; J Forgo; B Mrkic; H Murer
Journal:  Pflugers Arch       Date:  1993-09       Impact factor: 3.657

Review 4.  Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.

Authors:  K L Dechant; K L Goa
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.